Healthcare provider profile · identity verified

Cecilia S Kim, M.D.

Geriatric Medicine · WASHINTON, DC · NPI 1841551439

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	314	50
Eliquis	Apixaban	230	36
Levothyroxine Sodium	Levothyroxine Sodium	228	42
Gabapentin	Gabapentin	202	28
Amlodipine Besylate	Amlodipine Besylate	179	35
Pantoprazole Sodium	Pantoprazole Sodium	165	27
Escitalopram Oxalate	Escitalopram Oxalate	151	17
Furosemide	Furosemide	138	34
Mirtazapine	Mirtazapine	138	20
Losartan Potassium	Losartan Potassium	134	20
Memantine Hcl	Memantine Hcl	132	16
Donepezil Hcl	Donepezil Hcl	123	13
Sertraline Hcl	Sertraline Hcl	116	17
Metoprolol Tartrate	Metoprolol Tartrate	114	26
Lisinopril	Lisinopril	85	16
Metoprolol Succinate	Metoprolol Succinate	82	18
Xarelto	Rivaroxaban	79	suppressed
Famotidine	Famotidine	75	17
Duloxetine Hcl	Duloxetine Hcl	68	suppressed
Omeprazole	Omeprazole	67	11
Hydralazine Hcl	Hydralazine Hcl	63	16
Pravastatin Sodium	Pravastatin Sodium	54	11
Spironolactone	Spironolactone	51	suppressed
Myrbetriq	Mirabegron	49	suppressed
Divalproex Sodium	Divalproex Sodium	46	suppressed
Carvedilol	Carvedilol	44	suppressed
Montelukast Sodium	Montelukast Sodium	42	suppressed
Trazodone Hcl	Trazodone Hcl	41	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	40	13
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	35	suppressed
Risperidone	Risperidone	35	suppressed
Bupropion Xl	Bupropion Hcl	34	suppressed
Restasis	Cyclosporine	34	suppressed
Alendronate Sodium	Alendronate Sodium	31	suppressed
Bumetanide	Bumetanide	31	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Prednisone	Prednisone	28	suppressed
Potassium Chloride	Potassium Chloride	27	suppressed
Morphine Sulfate	Morphine Sulfate	26	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	25	suppressed
Finasteride	Finasteride	24	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	11
Lovastatin	Lovastatin	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	21
Tramadol Hcl	Tramadol Hcl	24	suppressed
Amiodarone Hcl	Amiodarone Hcl	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Atenolol	Atenolol	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	12
Veltassa	Patiromer Calcium Sorbitex	21	suppressed
Cephalexin	Cephalexin	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Rivastigmine	Rivastigmine Tartrate	20	suppressed
Jardiance	Empagliflozin	19	suppressed
Klayesta	Nystatin	18	11
Azelastine Hcl	Azelastine Hcl	16	suppressed
Benztropine Mesylate	Benztropine Mesylate	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Methimazole	Methimazole	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Torsemide	Torsemide	15	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	14	suppressed
Cefdinir	Cefdinir	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Metformin Hcl	Metformin Hcl	14	suppressed
Primidone	Primidone	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Brilinta	Ticagrelor	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Lactulose	Lactulose	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Alphagan P	Brimonidine Tartrate	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Movantik	Naloxegol Oxalate	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Ssd	Silver Sulfadiazine	12	suppressed
Topiramate	Topiramate	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Trimethoprim	Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error